Full Schedule

Chair: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Speaker: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Speaker: Elias K. Mai (he/him/his) – Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Speaker: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Panelist: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Panelist: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Panelist: Elias K. Mai (he/him/his) – Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Panelist: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Co-Chair: Meral Beksac, MD (she/her/hers) – Istinye University

Co-Chair: Michael O'Dwyer, MD – University of Galway, Galway, Ireland

Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Speaker: Yael C. Cohen, MD (she/her/hers) – Tel- Aviv Sourasky (Ichilov) Medical Center, and Faculty of health Science, Tel Aviv University, Tel Aviv, Israel

Speaker: Myo Htut, MD – City of Hope Comprehensive Cancer Center

Speaker: Yael C. Cohen, MD (she/her/hers) – Tel- Aviv Sourasky (Ichilov) Medical Center, and Faculty of health Science, Tel Aviv University, Tel Aviv, Israel

Speaker: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Co-Chair: Manoj Bhasin, PhD – Emory University

Co-Chair: Francesco Maura, MD – University of Miami

Speaker: Dipal Mehta, MBBS MRCP (he/him/his) – UCL Cancer Institute, University College London

Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Speaker: Wenqiang Yan, MD – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Speaker: Selma Bekri, PhD (she/her/hers) – Tisch Cancer Institute, Icahn School of Medicine at Mt. Sinai

Speaker: Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute

Co-Chair: Steven P. Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana-Farber Cancer Institute, Bing Center for Waldenstroms macroglobulinemia

Co-Chair: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Speaker: Roberto Garcia-Vicente, MSc (he/him/his) – Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain

Speaker: Surbhi Sidana, surbhi.sidana@stanford.edu – Stanford University

Speaker: Ioannis V. Kostopoulos, MSc, PhD (he/him/his) – Flow Cytometry Unit, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece

Speaker: Tadeusz Kubicki, MD, PhD – University of Chicago

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Ajai Chari, MD, PhD – University of California, San Francisco

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Speaker: Paola Neri, MD, PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary

Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Panelist: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC

Panelist: Ajai Chari, MD, PhD – University of California, San Francisco

Panelist: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Panelist: Paola Neri, MD, PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary

Panelist: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Speaker: Ramon Garcia Sanz, PhD (he/him/his) – Dept. of Hematology, University Hospital of Salamanca

Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Speaker: Surbhi Sidana, surbhi.sidana@stanford.edu – Stanford University

Speaker: Hira Mian, MD, MSc, FRCPC (she/her/hers) – McMaster University, Hamilton, Ontario, Canada

Co-Chair: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Niccolo Bolli, MD, PhD – University of Milan

Panelist: Niccolo Bolli, MD, PhD – University of Milan

Speaker: Jose Angel Martinez-Climent, MD PhD – University of Navarra, Center for Applied Medical Research, Department of Hematology, Clinica Universidad de Navarra Cancer Center, School of Medicine

Panelist: Jose Angel Martinez-Climent, MD PhD – University of Navarra, Center for Applied Medical Research, Department of Hematology, Clinica Universidad de Navarra Cancer Center, School of Medicine

Speaker: Josefine Krüger, MD – Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Panelist: Josefine Krüger, MD – Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Speaker: Sara Taranto, PhD (she/her/hers) – ASST Spedali Civili di Brescia

Panelist: Sara Taranto, PhD (she/her/hers) – ASST Spedali Civili di Brescia

Co-Chair: Leif Bergsagel, MD – Mayo Clinic Arizona

Co-Chair: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

Discussant: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Saad Z. Usmani, MD MBA – Memorial Sloan Kettering Cancer Center

Discussant: Noopur Raje, MD – Massachusetts General Hospital Cancer Center

Speaker: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA

Discussant: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Speaker: Romanos Sklavenitis-Pistofidis, MD, PhD – Dana-Farber Cancer Institute

Discussant: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Speaker: Ashraf Z. Badros, MD – The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD, USA

Discussant: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Speaker: Jesus G. Berdeja, MD – Tennessee Oncology

Speaker: Natalia P. Schütz (she/her/hers) – Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

Speaker: Jorge J. Castillo, MD – Bing Center for Waldenstrom Macroglobulinemia

Speaker: Prashant Kapoor, MD – Mayo Clinic

Co-Chair: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration

Speaker: Bindu Kanapuru, MD – Food and Drug Administration

Speaker: Edward Laane, MD, PhD (he/him/his) – Tartu University

Speaker: Michal Zwiewka, MD – Paul-Ehrlich-Institut

Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration

Speaker: Bindu Kanapuru, MD – Food and Drug Administration

Speaker: Edward Laane, MD, PhD (he/him/his) – Tartu University

Speaker: Michal Zwiewka, MD – Paul-Ehrlich-Institut

Co-Chair: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine

Co-Chair: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain

Speaker: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Speaker: Bhagirathbhai Dholaria, MBBS (he/him/his) – Vanderbilt-Ingram Cancer Center, Nashville, TN

Speaker: Doris K. Hansen, MD – Moffiitt Cancer Center

Speaker: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Speaker: Binod Dhakal, MD, MS – Medical College of Wisconsin, Milwaukee, WI, USA

Co-Chair: Jens Hillengass, MD, PhD (he/him/his) – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Co-Chair: Nicola Giuliani, MD, PhD – Department of Medicine and Surgery, University of Parma, Parma, Italy

Speaker: Joaquín Martínez-López – Hospital 12 de Octubre, Madrid

Speaker: Joshua Gustine, MD – Massachusetts General Hospital

Speaker: Holly Lee, MD – University of Calgary

Speaker: Marco Talarico, MD – Università di Bologna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli"

Speaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Discussant: Efstathios Kastritis, MD, PhD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Poster Presenter: Eric M. Jurgens, MD – Department of Medicine, Memorial Sloan Kettering Cancer Center

Discussant: Noa Biran, MD (she/her/hers) – Hackensack Meridian Health School of Medicine; The John Theurer Cancer Center

Poster Presenter: Attaya Suvannasankha, MD – Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, IN, USA

Discussant: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.

Poster Presenter: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA

Poster Presenter: yijie wang – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Discussant: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Discussant: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.

Poster Presenter: Borja Puertas (he/him/his) – Hospital Universitario de Salamanca

Discussant: Noa Biran, MD (she/her/hers) – Hackensack Meridian Health School of Medicine; The John Theurer Cancer Center

Poster Presenter: Nathan Martin, PhD (he/him/his) – Bristol Myers Squibb

Discussant: Efstathios Kastritis, MD, PhD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Poster Presenter: Oumaima Jaouadi, Ph.D – Melvin and Bren Simon Comprehensive Cancer Center

Discussant: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Poster Presenter: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Discussant: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Poster Presenter: Natalia Buenache – Hospital Universitario 12 Octubre

Discussant: Noa Biran, MD (she/her/hers) – Hackensack Meridian Health School of Medicine; The John Theurer Cancer Center

Poster Presenter: Cecilia Bonolo de Campos, MSc PhD – Princess Margaret Cancer Center - UHN

Discussant: Efstathios Kastritis, MD, PhD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Poster Presenter: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US